Cited by 89Blood Pressure and Hypertension StudiesAntiplatelet Therapy and Cardiovascular DiseasesEicosanoids and Hypertension Pharmacology

Low-dose aspirin does not interfere with the blood pressure-lowering effects of antihypertensive therapy.

Zanchetti, Alberto, Hansson, Lennart, Leonetti, Gastone, Rahn, Karl-Heinz, Ruilope, Luis, Warnold, Ingrid, Wedel, Hans·2002·Journal of Hypertension

Abstract

BACKGROUND: It has been reported that aspirin (ASA) may interfere with the blood pressure (BP)-lowering effect of various antihypertensive agents and attenuate the beneficial effects of angiotensin-converting enzyme (ACE) inhibitors in patients with congestive heart failure. METHODS AND RESULTS: Data from the Hypertension Optimal Treatment (HOT) Study, in which 18 790 intensively treated hypertensive patients were randomized to either ASA 75 mg daily or placebo for 3.8 years (with a 15% reduction in cardiovascular events and a 36% reduction in myocardial infarction in ASA-treated patients), were reanalysed for the whole group of patients and for various subgroups with particular attention to the possible effects of ASA on BP and renal function. In ASA-treated and placebo-treated patients: (1) systolic blood pressure (SBP) and diastolic blood pressure (DBP) values achieved with antihypertensive treatment were superimposable, with clinically irrelevant differences; (2) these superimposable SBP and DBP were achieved with antihypertensive therapies, that were quantitatively and qualitatively similar, and (3) changes in serum creatinine and in estimated creatinine clearance and the number of patients developing renal dysfunction were also similar. Furthermore, the cardiovascular benefits of ASA were of the same magnitude in hypertensive patients receiving or not receiving ACE-inhibitors. CONCLUSIONS: Even long-term, low-dose ASA does not interfere with the BP-lowering effect of antihypertensive agents, including combinations with ACE inhibitors, or with renal function. No negative interaction occurs between ACE inhibition and the cardiovascular benefits of small dose of ASA. Our conclusions cannot be extended to larger doses of ASA, or to patients with congestive heart failure.

Integrity signals

Registry

Crossref · 10.1097/00004872-200205000-00038

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zanchetti, A., Hansson, L., Leonetti, G., Rahn, K.-H., Ruilope, L., Warnold, I., & Wedel, H.
Affiliations
  • University of Milan (IT)
  • Uppsala University (SE)
Corresponding author
Zanchetti, Alberto
Venue
Journal of Hypertension
Published
2002-05
Volume
20
Issue
5
Pages
1015-1022
ISSN
0263-6352 (ISSN-L)
OpenAlex
W2075032872
Cited by
89
References
27
Citations by year
2025: 1 · 2024: 5 · 2023: 1 · 2022: 2 · 2020: 1 · 2019: 4 · 2018: 3 · 2017: 3 · 2016: 1 · 2015: 3 · 2014: 3 · 2013: 4 · 2012: 13
FWCI
3.64
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Hypertension (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
Keywords
low-dose aspirin, antihypertensive therapy, antihypertensive effect, ACE inhibitors, drug interactions, renal function, creatinine clearance, serum creatinine, hypertension, cardiovascular benefits, HOT study
MeSH terms
Aged, Antihypertensive Agents, Aspirin, Blood Pressure, Cardiovascular Diseases, Cardiovascular System, Diastole, Dose-Response Relationship, Drug, Double-Blind Method, Drug Interactions, Female, Humans, Hypertension, Kidney, Male, Middle Aged, Platelet Aggregation Inhibitors, Systole

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review